Gene178
AGL: amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase
Cite this record
ConductScience Library. AGL: amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase. Genes, record 178. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/178
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P35573 | Glycogen debranching enzyme | 1,532 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents404
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260242762 A1 | 2026-08-20 | 1 | P35573 | Espacenet |
| US 12703858 B2 | 2026-08-11 | 2 | P35573 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 3160 | P35573 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 342 | P35573 | Espacenet |
| JP 2026067851 A | 2026-04-21 | 112 | P35573 | Espacenet |
| US 12508305 B2 | 2025-12-30 | 2 | P35573 | Espacenet |
| US 20250376534 A1 | 2025-12-11 | 3652 | P35573 | Espacenet |
| US 20250369018 A1 | 2025-12-04 | 212 | P35573 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 3574 | P35573 | Espacenet |
| JP 2025169942 A | 2025-11-14 | 803 | P35573 | Espacenet |
NIH grants372
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AGL papers | Newest fiscal year |
|---|---|---|---|
| P30CA177558 | University of Kentucky Markey Cancer Center – Cancer Center Support Grant | 5 | 2025 |
| D43TW007393 | Emerge, Leaders in Emerging Diseases Epidemiology Research Training | 4 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 4 | 2025 |
| P20GM121327 | University of Kentucky Center for Cancer Metabolism | 3 | 2025 |
| R35NS116824 | Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential | 3 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 2 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 2 | 2025 |
| T32CA165990 | Interdisciplinary Research Training in Cancer Biology | 2 | 2025 |
| UL1TR001998 | Kentucky Center for Clinical and Translational Science | 2 | 2025 |
Source NIH's project files
Papers841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of novel and known variants in GAA, MYH6, NEXN, ATA3A, RHBDF1, and ACTA1 genes in coronary artery disease patients by Whole-exome sequencing. | Front Cardiovasc Med | 2026 | 42760933 | PubTator, text mining | PubMed |
| Systematic genetic, biochemical, and lipidomic characterization of GSD III fibroblast models reveals mis-annotation and defines a conserved disease lipid signature. | Mol Genet Metab | 2026 | 42679456 | PubTator, text mining | PubMed |
| Off-Target Binding of Miglustat to Glycogen Debranching Enzyme. | Int J Mol Sci | 2026 | 42353206 | PubTator, text mining | PubMed |
| Association Analysis of GABRA5, SOX13, and AGL Gene Polymorphisms with Growth Traits in Dongfeng Sika Deer. | Biology (Basel) | 2026 | 42274532 | PubTator, text mining | PubMed |
| A Case Report of Glycogen Storage Disorder Type IIIa in a Pediatric Patient: Clinical Approach and Molecular Diagnosis. | Ann Afr Med | 2026 | 42260950 | PubTator, text mining | PubMed |
| Dysregulation of glycogen metabolism in cardiomyopathy caused by glycogenin-1 (GYG1) missense variants. | J Clin Endocrinol Metab | 2026 | 42165248 | PubTator, text mining | PubMed |
| Flower-like WO3-modified Vulcan carbon GDEs for photoelectro-Fenton process: Efficient ciprofloxacin degradation and mechanistic insights. | J Environ Manage | 2026 | 41955996 | PubTator, text mining | PubMed |
| Fabrication and Characterization of Lignocellulose-Based Porous Materials via Chemical Crosslinking. | Gels | 2026 | 41745012 | PubTator, text mining | PubMed |
| Glycogen storage disease type IX: Long-term follow-up of 52 patients from three European countries. | Mol Genet Metab Rep | 2026 | 41732189 | PubTator, text mining | PubMed |
| Cardiopulmonary and skeletal muscle strategies underlying exhaustive exercise in adults with glycogen storage disease type III. | Physiol Rep | 2026 | 41725048 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/178
GET https://conductscience.org/api/genes/v1/178/patents?page=2